If you purchased or otherwise acquired Bio-One Corporation (“Bio-One”) common stock between February 4, 2004 and May 9, 2005, inclusive, and were damaged thereby, then you could get a payment from a class action settlement.

The Complaint alleges that Bio-One filed false and misleading financial reports with the United States Securities and Exchange Commission (the “SEC”) during the Class Period. The Complaint alleges that these reports failed to disclose that Bio-One did not have the capital, expertise, or personnel to succeed with its business plan of acquiring multiple nutritional supplement companies and that Bio-One had defaulted on a promissory note in connection with its acquisition of Interactive Nutritional International (“INI”).

The Complaint further alleges that Bio-One’s former CEO, Dauplaise, used the company’s bank accounts as if they were his own and that the Bio-One failed to disclose the fact that Dauplaise’s son was acting as its de facto treasurer.

The lawsuit seeks money damages against the Defendants for violations of the federal securities laws. The Defendants deny all allegations of misconduct contained in the Complaint, and deny having engaged in any wrongdoing whatsoever.

Note: This website is provided as a service to potential class members. The information provided is in summary form and is not intended as a complete explanation of your rights. For full and complete information, you are directed to review carefully the Notice of Pendency of Class Action and Proposed Settlement and Proof of Claim and Release Form.